Collaborative drug discovery programs
Schrödinger has wholly owned and collaborative programs in a broad range of therapeutic areas.
Source: LinkedIn company description · Retrieved November 17, 2026

Schrödinger provides a computational platform that facilitates research for biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide.
Schrödinger has wholly owned and collaborative drug discovery programs across a broad range of therapeutic areas. Schrödinger is engaged with customers and collaborators in more than 70 countries.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Schrödinger has wholly owned and collaborative programs in a broad range of therapeutic areas.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.